Motivational Enhancement Therapy to Improve Treatment Utilization and Outcome in Pregnant Substance Users

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current information on nida.nih.gov.

About 5% of women use illicit substances during pregnancy, and approximately 22% of these also report using tobacco or alcohol. While a number of treatment programs have begun to offer treatment specifically designed for pregnant substance abusers, it is difficult to keep these women in treatment. Brief motivational sessions have been found to improve treatment engagement and outcomes in both alcohol- and drug-using women. This study compared one such treatment intervention, Motivational Enhancement Therapy (MET), with standard treatment. The three individual MET sessions focused on developing rapport, exploring perceived pros and cons of using substances, reviewing the participant's feedback on the consequences of substance use and the status of her pregnancy, and developing a change plan or strengthening the commitment to change. Patients assigned to standard treatment received an equal number of visits consisting of the treatment normally given in that clinic.

CTN Protocol ID: 
CTN-0013
DSMB ID: 
DSMB-0013
ClinicalTrials.gov ID: 

Principal Investigator(s)

Theresa Winhusen, Ph.D.
Professor of Psychiatry and Behavioral Neuroscience, Director of Addiction Sciences Division 
University of Cincinnati
Addiction Sciences Division
3131 Harvey Avenue, Suite 104
Cincinnati, OH 45229-3006
winhust@ucmail.uc.edu

Static CTPS

Participating Sites